Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue allografts and health risks

C Delloye1

  • 1Division of Orthopedic Surgery, St-Luc University Clinics, Brussels, Belgium.

Acta Orthopaedica Belgica
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Tissue allografts can transmit viral diseases like HIV and HCV. Rigorous donor screening and tissue quarantine are essential to minimize disease transmission risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Is there still a place for bone allografts in orthopedic surgery in 2011?].

Bulletin et memoires de l'Academie royale de medecine de Belgique·2012
Same author

Forearm reconstruction with bone allograft following tumor excision: a series of 10 patients with a mean follow-up of 10 years.

Orthopaedics & traumatology, surgery & research : OTSR·2011
Same author

Freeze-dried allograft versus autograft bone in scoliosis surgery. A retrospective comparative study.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2010
Same author

Human tissue allograft processing: impact on in vitro and in vivo biocompatibility.

Journal of materials science. Materials in medicine·2009
Same author

Bone allografts: What they can offer and what they cannot.

The Journal of bone and joint surgery. British volume·2007
Same author

In vitro evaluation of acute cytotoxicity of human chemically treated allografts.

European cells & materials·2006

Area of Science:

  • Transplantation immunology
  • Infectious disease transmission
  • Tissue banking protocols

Background:

  • Tissue allografts, similar to vascularized transplants, pose a risk of transmitting viral and bacterial infections.
  • Documented transmission of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) has occurred through sterilized, unprocessed, and deep-frozen allografts.
  • Standard donor screening may not identify all contaminated donors, particularly those who are seronegative.

Purpose of the Study:

  • To highlight the risks associated with disease transmission via tissue allografts.
  • To emphasize the critical role of tissue banks in donor selection and screening.
  • To advocate for enhanced safety measures in tissue procurement and processing.

Main Methods:

Related Experiment Videos

  • Review of existing literature on disease transmission through tissue allografts.
  • Analysis of standard tissue banking procedures and their limitations.
  • Discussion of complementary screening and quarantine protocols.

    • Main Results:

    • HIV and HCV transmission are proven risks associated with allografts.
    • Standard biological screening is insufficient to detect all contaminated donors.
    • Quarantine and secondary screening are necessary for contaminated tissues.

    Conclusions:

    • Meticulous donor selection and comprehensive biological screening are paramount responsibilities of tissue banks.
    • Quarantining tissues until complementary screening confirms viral absence is crucial.
    • Implementing robust screening and procurement practices significantly minimizes the risk of disease transmission from tissue allografts.